Retrophin, Inc. (NASDAQ:RTRX) A Buying Opportunity

By HEFFX Australia on June 14, 2020   2020, Headline News, Health, Heffx Insights, Investments, MetaStock, Nasdaq, Opinion, Shayne Heffernan, Shayne Heffernan, Stocks, Todays Trade Ideas, Top Stories, US Stocks  

Retrophin, Inc. (NASDAQ:RTRX) A Buying Opportunity Tech giants see healthcare and pharma as the next big thing RetrophinTicker: NASDAQ:RTRXPrice: $15.32 The global biopharmaceuticals market is found witnessing a CAGR of 7.14%. The market is largely driven by the growing geriatric population, increasing burden of chronic diseases, and rising inclination toward targeted therapy. Also, the huge […]